C07C 311/40
To an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound
Official title: to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
C07C311/40 (To an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound) appears on 28 US grants and 26 published applications in this corpus.
Search patents in C07C- Granted patents
- 28
- Published applications
- 26
- Assignees
- 35
- Inventors
- 151
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 2 | 1 |
| 2008 | 1 | 2 |
| 2009 | 2 | 1 |
| 2010 | 1 | 2 |
| 2011 | 2 | 1 |
| 2012 | 0 | 1 |
| 2013 | 3 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 2 | 3 |
| 2023 | 0 | 3 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzenesulfonamide derivatives and uses thereof24 Feb 2026US 12,559,454 B22692372 Ontario, Inc.
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- Sulfonated 2(7)-aminoacridone and 1-aminopyrene dyes and their use as fluorescent tags, in particular for carbohydrate analysis24 Dec 2024US 12,174,197 B2MAX-PLANCK-GESELLSCHAFT zur FOERDERUNG der WISSENSCHAFTEN.e.V
- Aromatic sulfonamide derivatives13 Dec 2022US 11,524,938 B2Bayer Pharma Aktiengesellschaft
- 3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. stroke24 May 2022US 11,339,124 B2Universiteit Antwerpen
- Methods and Compositions for Targeting Tregs using CCR8 Inhibitors25 May 2023US 2023/0159446 A1Nanjing Immunophage Biomedical Co., Ltd.
- Fused ring compound and application thereof20 Apr 2023US 2023/0118751 A1Wuhan Ll Science and Technology Development Co., Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors9 Feb 2023US 2023/0038589 A1Nanjing Immunophage Biotech Co., Ltd.
- Aromatic sulfonamide derivatives13 Oct 2022US 2022/0324807 A1Bayer Pharma Aktiengesellschaft
- Benzenesulfonamide derivatives and uses thereof8 Sep 2022US 2022/0281812 A12692372 Ontario, Inc.
Most cited
By later US patents
- Anthranilic acid derivatives78US 5,716,993 AEisai Co., Ltd. · 1998
- Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation19US 5,240,464 AMilliken Research Corporation · 1993
- Sulfamoyl benzamides and methods of their use17US 7,544,676 B2Adolor Corporation · 2009
- Inhibitors of factor Xa15US 6,545,055 B1Millennium Pharmaceuticals, Inc. · 2003
- Method of using fluorosubstituted benzene derivatives in F-NMR imaging11US 5,130,119 ASchering Corporation · 1992